| scholarly article | Q13442814 |
| P2093 | author name string | Yasong Du | |
| Wei Wu | |||
| Min Zhao | |||
| Xiaohong Li | |||
| Shunying Yu | |||
| Jijun Li | |||
| Yingmei Fu | |||
| Donghong Cui | |||
| Jianling Chen | |||
| P2860 | cites work | The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative | Q24620663 |
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2 | Q28209958 | ||
| Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder | Q30534798 | ||
| Valproic acid in pregnancy: how much are we endangering the embryo and fetus? | Q34984538 | ||
| Breastfeeding, infant formula supplementation, and Autistic Disorder: the results of a parent survey | Q35052232 | ||
| Autistic children exhibit decreased levels of essential Fatty acids in red blood cells | Q35723146 | ||
| Critical phosphorylation sites for acetyl-CoA carboxylase activity. | Q36722109 | ||
| Developmental profiles of lipogenic enzymes and their regulators in the neonatal mouse brain | Q37352030 | ||
| Valproic acid is a novel activator of AMP-activated protein kinase and decreases liver mass, hepatic fat accumulation, and serum glucose in obese mice | Q37405427 | ||
| Mitochondrial dysfunction in autism | Q37558748 | ||
| Microscopic neuroanatomic abnormalities in autism | Q37703177 | ||
| Alterations of neocortical development and maturation in autism: insight from valproic acid exposure and animal models of autism | Q38042500 | ||
| Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders | Q38198830 | ||
| Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells. | Q38949147 | ||
| Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro | Q39068761 | ||
| The ketogenic diet modifies social and metabolic alterations identified in the prenatal valproic acid model of autism spectrum disorder | Q39161646 | ||
| Globular adiponectin regulates energy homeostasis through AMP-activated protein kinase-acetyl-CoA carboxylase (AMPK/ACC) pathway in the hypothalamus | Q39681057 | ||
| Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells | Q39847467 | ||
| Linking etiologies in humans and animal models: studies of autism | Q41429994 | ||
| Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders | Q43092496 | ||
| Up-regulation of Ras/Raf/ERK1/2 signaling impairs cultured neuronal cell migration, neurogenesis, synapse formation, and dendritic spine development | Q43538904 | ||
| Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse | Q43758997 | ||
| Up-regulation of Ras/Raf/ERK1/2 signaling in the spinal cord impairs neural cell migration, neurogenesis, synapse formation, and dendritic spine development | Q44769281 | ||
| Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase | Q44895596 | ||
| Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism | Q44967603 | ||
| Ketogenic diet attenuates kainic acid-induced hippocampal cell death by decreasing AMPK/ACC pathway activity and HSP70. | Q46018201 | ||
| Role of polyunsaturated fatty acids in the management of Egyptian children with autism | Q46517246 | ||
| Study of the serum levels of polyunsaturated fatty acids and the expression of related liver metabolic enzymes in a rat valproate-induced autism model | Q47656666 | ||
| The 16p11.2 deletion mouse model of autism exhibits altered cortical progenitor proliferation and brain cytoarchitecture linked to the ERK MAPK pathway. | Q47675041 | ||
| Brain acetyl-CoA carboxylase: isozymic identification and studies of its regulation during development and altered nutrition | Q48301041 | ||
| Class I histone deacetylase inhibition ameliorates social cognition and cell adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder | Q48478335 | ||
| Long-chain acyl-CoA dehydrogenase is a key enzyme in the mitochondrial beta-oxidation of unsaturated fatty acids | Q73835660 | ||
| P433 | issue | 3 | |
| P921 | main subject | autism | Q38404 |
| fatty acid | Q61476 | ||
| P304 | page(s) | 1293-1298 | |
| P577 | publication date | 2016-07-05 | |
| P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
| P1476 | title | Increased expression of fatty acid synthase and acetyl-CoA carboxylase in the prefrontal cortex and cerebellum in the valproic acid model of autism | |
| P478 | volume | 12 |
Search more.